What question did this study set out to answer?

This research aims to develop a new method for targeted delivery of doxorubicin using immuno-nanoparticles.

Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial demonstrates increased apoptosis in HER2-positive breast cancer cells using nanoparticle delivery.

This research aims to develop a new method for targeted delivery of doxorubicin using immuno-nanoparticles.
Utilized polymeric nanoparticles with surface furan groups for Diels–Alder coupling.
Conjugated anti-HER2 antibodies and doxorubicin for targeted delivery.
Analyzed nuclear localization and cytotoxic effects on SKBR-3 cells.
Combined DOX-anti-HER2 nanoparticle achieved greater cytotoxicity in SKBR-3 cells compared to free DOX (p<0.01).
Free DOX had similar effects on cancerous and healthy cells, whereas the nanoparticle targeting was more effective.
DOX maintained its biological function and apoptotic induction when delivered via nanoparticles.

Shi et al. (2009) studied this question.

View Full Paper

Ask AI

Bookmark